US 6210913
Modulation of integrin-mediated signal transduction
expired A61PA61P29/00A61P35/00
Quick answer
US patent 6210913 (Modulation of integrin-mediated signal transduction) held by COR Therapeutics, Inc. expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- COR Therapeutics, Inc.
- Grant date
- Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P29/00, A61P35/00, A61P43/00, A61P7/02